Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 172(6): 3527-34, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-15004153

ABSTRACT

Activation of the phosphatidylinositol-3 kinase (PI 3-K) pathway is associated with the proliferation of many cell types, including T lymphocytes. However, recent studies in cell lines stably expressing deletion mutants of IL-2R that fail to activate PI 3-K have questioned the requirement for this pathway in cell cycle regulation. In this study with IL-2 and IL-7, we show in primary T cells that, unlike IL-2, IL-7 fails to induce the early activation of PI 3-K seen within minutes and normally associated with cytokine signaling. However, kinetic experiments showed that both of these T cell growth factors induce a distinct and sustained phase of PI 3-K activity several hours after stimulation. This delayed activation correlates with cell cycle induction and from studies using inhibitors of PI 3-K signaling, we show that this later phase, unlike the early activation within minutes, is required for cell cycle induction. The data presented here will have major implications for our understanding of the mechanism of T cell proliferation as well as the regulation of PI 3-K activity.


Subject(s)
Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction/immunology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/enzymology , Animals , Cell Cycle/drug effects , Cell Cycle/immunology , Cell Differentiation/drug effects , Cell Differentiation/immunology , Cell Division/drug effects , Cell Division/immunology , Cell Line , Chromones/pharmacology , Cyclin E/antagonists & inhibitors , Cyclin E/biosynthesis , Cycloheximide/pharmacology , Enzyme Activation/drug effects , Enzyme Activation/immunology , Growth Inhibitors/pharmacology , Imidazoles/pharmacology , Interleukin-2/physiology , Interleukin-7/physiology , Lymphocyte Activation/immunology , Mice , Morpholines/pharmacology , Phosphatidylinositol 3-Kinases/physiology , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Pyridines/pharmacology , Retinoblastoma Protein/antagonists & inhibitors , Retinoblastoma Protein/metabolism , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...